Cargando…

Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India

Detalles Bibliográficos
Autores principales: Varshney, Amit, Rawat, Ramakant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/
https://www.ncbi.nlm.nih.gov/pubmed/37585983
http://dx.doi.org/10.1590/1806-9282.20230090
_version_ 1785090179954900992
author Varshney, Amit
Rawat, Ramakant
author_facet Varshney, Amit
Rawat, Ramakant
author_sort Varshney, Amit
collection PubMed
description
format Online
Article
Text
id pubmed-10427181
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Associação Médica Brasileira
record_format MEDLINE/PubMed
spelling pubmed-104271812023-08-16 Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India Varshney, Amit Rawat, Ramakant Rev Assoc Med Bras (1992) Review Article Associação Médica Brasileira 2023-08-14 /pmc/articles/PMC10427181/ /pubmed/37585983 http://dx.doi.org/10.1590/1806-9282.20230090 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Varshney, Amit
Rawat, Ramakant
Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title_full Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title_fullStr Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title_full_unstemmed Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title_short Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
title_sort comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in india
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427181/
https://www.ncbi.nlm.nih.gov/pubmed/37585983
http://dx.doi.org/10.1590/1806-9282.20230090
work_keys_str_mv AT varshneyamit comparisonofsafetyandefficacyofdapagliflozinandempagliflozinintype2diabetesmellituspatientsinindia
AT rawatramakant comparisonofsafetyandefficacyofdapagliflozinandempagliflozinintype2diabetesmellituspatientsinindia